Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vaxart, Inc. - Common Stock (NQ:VXRT)

0.5748 -0.0052 (-0.90%)
Streaming Delayed Price Updated: 2:04 PM EDT, Jun 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vaxart, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
VXRT Stock Earnings: Vaxart Meets EPS, Beats Revenue for Q1 2024
VXRT stock results show that Vaxart met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Vaxart Stock Climbs After Blockbuster Q1 Revenue
Vaxart reported quarterly losses of 14 cents per share, inline with the analyst consensus estimate. Quarterly sales clocked in at $2.181 million, beating the analyst consensus estimate of $800,000 by... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around. 
Via InvestorPlace
Recap: Vaxart Q4 Earnings
Via Benzinga
Vaxart's Earnings: A Preview
Via Benzinga
What's Going On With Vaxart Stock Today?
Vaxart shares are trading higher by around 8% Wednesday afternoon. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services. 
Via Benzinga
VXRT Stock Earnings: Vaxart Beats EPS, Beats Revenue for Q4 2023
VXRT stock results show that Vaxart beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
Vaxart's Earnings Outlook
Via Benzinga
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
Why Vaxart Stock Is Tumbling Today
Vaxart Inc (NASDAQ: VXRT) shares are trading lower Wednesday after the company proposed a public offering of common stock. 
Via Benzinga
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
What's Going On With Vaxart (VXRT) Stock?
Vaxart shares are trading higher by 17.8% Tuesday morning amid multiple news items. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services. 
Via Benzinga
Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage! 
Via InvestorPlace
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. 
Via Benzinga
3 Biotech Blockbusters to Turn $5,000 Into $50,000
These transformative early-stage biotech stocks can deliver triple-digit upside if their key milestones are achieved on time. 
Via InvestorPlace
Vaxart's Oral Vaccine For Stomach Bug Shows Reduction In Infection Rate
Vaxart Inc (NASDAQ: VXRT) released topline data from the Phase 2 challenge study of its oral tablet monovalent  
Via Benzinga
Vaxart Touts Encouraging Positive Preliminary Data From Bivalent Norovirus Vaccine Study
Vaxart Inc (NASDAQ: VXRT) announced topline data from the dose-ranging Phase 2 trial of its oral pill  
Via Benzinga
Crude Oil Rises Over 1%; United Natural Foods Posts Downbeat Results
U.S. stocks traded mixed toward the end of trading, with Dow Jones gaining around 100 points on Wednesday. The Dow traded up 0.30% to 33,672.74 while the NASDAQ fell 1.11% to 13,129.19. The S&P 500,... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for... 
Via Benzinga
Nasdaq Drops Over 100 Points; Campbell Soup Earnings Beat Estimates
U.S. stocks traded mixed midway through trading, with Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded up 0.20% to 33,639.18 while the NASDAQ fell 0.90% to 13,156.82. The S&P 500,... 
Via Benzinga
PLTR Stock Alert: Palantir Announces Partnership With Panasonic
Palantir (PLTR) stock is getting a boost on Wednesday after the big data company announced a partnership with Panasonic (PCRFY). 
Via InvestorPlace
Why Is Vaxart (VXRT) Stock Down 25% Today?
Vaxart (VXRT) stock is taking a beating on Wednesday as investors react to the company announcing a proposed public share offering. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.